Siming Li
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Biochemistry top 5%
Papers in
- Oncology 32
- Cutaneous Melanoma Detection and Management 18
- Cancer Immunotherapy and Biomarkers 17
-
- Traditional Chinese Medicine Analysis 6
- Cardiovascular and exercise physiology 2
- Co-authors
- Xinan Sheng (37 shared papers)Zhihong Chi (34 shared papers)Lu Si (34 shared papers)Chuanliang Cui (34 shared papers)Jun Guo (25 shared papers)Bixia Tang (32 shared papers)Lili Mao (28 shared papers)Yan Kong (22 shared papers)
- Journals
- European Journal of Cancer (7 papers)Evidence-based Complementary and Alternative Medicine (3 papers)Frontiers in Oncology (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Siming Li
66 papers receiving 2.3k citations
Siming Li's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 801
- Biochemistry 73
- Complementary and alternative medicine 100
- Cancer Research 115
- Molecular Biology 513
Countries citing papers authored by Siming Li
This map shows the geographic impact of Siming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siming Li more than expected).
Fields of papers citing papers by Siming Li
This network shows the impact of papers produced by Siming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siming Li. The network helps show where Siming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Siming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP Hit paper breakdown → | 2005 | 541 |
| 2 | 2019 | 149 | |
| 3 | 2013 | 146 | |
| 4 | 2019 | 131 | |
| 5 | 2021 | 106 | |
| 6 | 2017 | 79 | |
| 7 | 2016 | 59 | |
| 8 | 2019 | 55 | |
| 9 | 2015 | 51 | |
| 10 | 2014 | 42 | |
| 11 | 2021 | 42 | |
| 12 | 2022 | 41 | |
| 13 | 2018 | 40 | |
| 14 | 2018 | 39 | |
| 15 | 2011 | 38 | |
| 16 | 2017 | 38 | |
| 17 | 2018 | 38 | |
| 18 | 2020 | 38 | |
| 19 | 2020 | 36 | |
| 20 | 2013 | 34 |
About Siming Li
Siming Li is a scholar working on Oncology, Complementary and alternative medicine, Pulmonary and Respiratory Medicine, Neurology and Cardiology and Cardiovascular Medicine, having authored 68 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (18 papers), Cancer Immunotherapy and Biomarkers (17 papers), Renal cell carcinoma treatment (8 papers), Traditional Chinese Medicine Analysis (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Melanoma and MAPK Pathways (5 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Cardiovascular and exercise physiology (2 papers). The work is most often cited by research in Oncology (801 citations), Biochemistry (73 citations), Complementary and alternative medicine (100 citations), Cancer Research (115 citations) and Molecular Biology (513 citations). Siming Li has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Xinan Sheng, Zhihong Chi, Lu Si, Chuanliang Cui, Jun Guo, Bixia Tang, Lili Mao, Yan Kong, Bin Lian and Jiandie D. Lin. Their work appears in journals such as European Journal of Cancer, Evidence-based Complementary and Alternative Medicine, Frontiers in Oncology, Journal for ImmunoTherapy of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.